Search results
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 10 hours agoWhy it matters: It's a major turnaround for Maryland-based Novavax, one of America's first big bets...
AstraZeneca pulls COVID-19 vaccine from global markets
United Press International via Yahoo News· 2 days agoBritish-Swedish drug maker AstaZeneca is pulling its Vaxzevria COVID-19 vaccine from sale globally....
AstraZeneca pulls its COVID-19 vaccine from the European market
WSLS Newschannel 10 Roanoke· 3 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 13 hours agoNovavax stock (NVAX) skyrocketed on Friday, gaining as much as 120% on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for Novavax's ...
AstraZeneca withdraws Covid-19 vaccine, citing low demand
CNN Business via AOL· 2 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 13 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 16 hours agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
AstraZeneca withdraws Covid-19 vaccine citing low demand - WTOP News
WTOP Washington· 3 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
AstraZeneca withdraws COVID-19 vaccine citing low demand
KCCI 8 Des Moines· 3 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
AstraZeneca withdraws Covid-19 vaccine, citing low demand - Boston News, Weather, Sports | WHDH...
7 News Boston· 2 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...